Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT07099677

Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk

Led by Abant Izzet Baysal University · Updated on 2026-02-12

186

Participants Needed

1

Research Sites

47 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare the short-term effects of three commonly prescribed antihypertensive drug classes (beta-blockers, ACE inhibitors, and calcium channel blockers) on postural balance and fall risk in adults with newly diagnosed primary hypertension. The main questions it aims to answer are: * Do different antihypertensive drugs affect objective balance performance and fall risk? * What are the effects of these medications on dizziness and fear of falling? Researchers will use a balance analysis system (Biodex Balance System) and self-reported scales (Dizziness Handicap Inventory and Falls Efficacy Scale) to assess outcomes. Participants will: * Be randomly assigned to one of three drug groups (metoprolol, ramipril, or amlodipine) * Be evaluated at baseline (prior to treatment), at 2 weeks, and at 4 weeks after starting treatment * Complete balance tests and questionnaires at each time point This study aims to provide clinical insight into how commonly used blood pressure medications may impact balance and fall risk in real-world settings.

CONDITIONS

Official Title

Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged between 18 and 75 years
  • Newly diagnosed with primary hypertension
  • No prior use of antihypertensive medication
  • No history of neurological, vestibular, orthopedic, or psychiatric conditions affecting balance
  • Able to walk independently without assistive devices
  • Provided written informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Secondary hypertension
  • Known diagnosis of vestibular disorders (e.g., BPPV, Ménière's disease)
  • Use of medications that may affect balance (e.g., sedatives, psychotropic drugs)
  • History of falls due to trauma unrelated to balance
  • Cognitive impairment preventing proper test participation
  • Inability to complete the assessments at follow-up timepoints (2nd and 4th week)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Bolu Abant Izzet Baysal University, Izzet Baysal Training and Research Hospital

Bolu, Turkey (Türkiye), 14030

Actively Recruiting

Loading map...

Research Team

A

Alp Ozel, PT, PhD

CONTACT

U

Umut A Ugras, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here